Concepedia

Julie Hambleton

JH

Statistics

Publications

19

Citations

3.9K

H-Index

16

Active since

1998

Affiliations

University of California, San Francisco(Current)

University of California, Los Angeles

Cerus (United States)

Western University

University of New Brunswick

Julie Hambleton is an author at University of California, San Francisco specializing in medicine, hemostasis, and hematology.

Publications per year

1998–2016

19

Publications

19

Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism

Clive Kearon, Jeffrey S. Ginsberg, Michael J. Kovacs et al. · New England Journal of Medicine · 2003 · 756 citations

, , +15

Phase II Study of Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer or Peritoneal Serous Cancer

Stephen A. Cannistra, Ursula A. Matulonis, Richard T. Penson et al. · Journal of Clinical Oncology · 2007 · 756 citations

, , +5

Combined Analysis of Efficacy: The Addition of Bevacizumab to Fluorouracil/Leucovorin Improves Survival for Patients With Metastatic Colorectal Cancer

Fairooz F. Kabbinavar, Julie Hambleton, R. Mass et al. · Journal of Clinical Oncology · 2005 · 689 citations

, , +14

Bevacizumab in Combination With Fluorouracil and Leucovorin: An Active Regimen for First-Line Metastatic Colorectal Cancer

Herbert I. Hurwitz, Louis Fehrenbacher, John D. Hainsworth et al. · Journal of Clinical Oncology · 2005 · 685 citations

, , +13

Treatment Outcomes by Tumor Histology in Eastern Cooperative Group Study E4599 of Bevacizumab with Paclitaxel/Carboplatin for Advanced Non-small Cell Lung Cancer

Alan Sandler, Jing Yi, Suzanne E. Dahlberg et al. · Journal of Thoracic Oncology · 2010 · 172 citations · Full text

, , +8

1–5 of 19